Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines

Interdisciplinary partnership between Saint-Gobain, Kanyr Pharma, and McGill in the development of optimised culture environments for dendritic cell cancer vaccines. (Credit: Business Wire)